Drugs and brain death

Drug Safety

Volumn 14, Issue 3, 1996, Pages 171-180

  Kennedy, Michael ^a,c   Kiloh, Neil ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b SUTHERLAND HOSPITAL   (Australia)

^c NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; DIAZEPAM; DRUG; FLURAZEPAM; HYPNOTIC SEDATIVE AGENT; MORPHINE; NEUROLEPTIC AGENT; NEUROTRANSMITTER; NITRAZEPAM; PANCURONIUM BROMIDE; PENTOBARBITAL; SUXAMETHONIUM; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTIFICIAL VENTILATION; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN DEATH; BRAIN STEM; BREATHING; CRITICAL ILLNESS; DIAGNOSTIC TEST; DRUG SCREENING; DRUG UPTAKE; ELECTROENCEPHALOGRAM; EVOKED RESPONSE; HUMAN; MEDICAL ASSESSMENT; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW;

EID: 0029995345     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199614030-00004     Document Type: Review

References (57)

1. Hutchesson P, Watson B, Schockett W, editors. The All England Law Reports. Airedale NHS Trust vs Bland. 1993 Mar; Pt 10: 821
2. Brierley JB, Adams JH, Graham DI, et al. Neocortical death after cardiac arrest. Lancet 1971; ii: 560-5
3. Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. A definition of irreversible coma. JAMA 1968; 205 (6): 337-40
4. Diagnosis of brain death. Statement by the honorary secretary of the Conference of Medical Royal Colleges and their Faculties in the United Kingdom. BMJ 1976; 2: 1187-8
5. Special Communication. Guidelines for the determination of Death. JAMA 1981; 246 (19): 2185-6
6. Searle J, Collins C. A brain-death protocol. Lancet 1980; i: 641-3
7. Black PM. Brain death: part I. N Engl J Med 1978; 299 (8): 338-44
8. Black PM. Brain death: part II. N Engl J Med 1978; 299 (8): 393-401
9. Pallis C. ABC of brain stem death: reappraising death. BMJ (Clin Res Ed) 1982; 285: 1409-12
10. Pallis C. ABC of brain stem death: from brain death to brain stem death. BMJ 1982; 285: 1487-90
11. Pallis C. ABC of brain stem death: diagnosis of brain stem death - 1. BMJ 1982; 285: 1558-60
12. Pallis C. ABC of brain stem death: diagnosis of brain stem death - 2. BMJ 1982; 285: 1643-4
13. Pallis C. ABC of brain stem death: pitfalls and safeguards. BMJ 1982; 285: 1720-2
14. Australian and New Zealand Intensive Care Society. Statement and guidelines on brain death and organ donation. Carlton (Vic): Australian and New Zealand Intensive Care Society, 1993
15. Dobb GJ, Weekes JW. Clinical confirmation of brain death. Anaesth Intensive Care 1995; 23: 37-43
16. Osternol J. Testing for drugs of abuse: pharmacokinetic considerations for cocaine in urine. Clin Pharmacokinet 1993; 24 (5): 255-61
17. Heinemeyer G. Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure. Clin Pharmacokinet 1987; 13: 1-25
18. Bodenham A, Shelly M, Park G. The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients. Clin Pharmacokinet 1988; 14: 347-73
19. Bass J, Miles MV, Tennison MB, et al. Effects of enteral tube feeding on the absorption and pharmacokinetic profile of carbamazepine suspension. Epilepsia 1989; 30: 364-9
20. Randall C, Tett S. Phenytoin pharmacokinetics after intravenous administration to patients receiving enteral tube feeding. Pharm World Sci 1994; 16 (4) 217-24
21. Cumming JF. The effect of arterial oxygen tension on antipyrine half-time in plasma. Clin Pharmacol Ther 1976; 19: 468-71
22. Perkins MW, Dasta JF, DeHaven B. Physiologic implications of mechanical ventilation on pharmacokinetics. Ann Pharmacother 1989; 23: 316-23
23. Milne RW, Nation RL, Somogyi AA, et al. The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive care patients. Br J Clin Pharmacol 1992; 34: 53-9
24. Boucher BA, Khul DA, Fabian TC, et al. The effect of neurotrauma on hepatic drug clearance. Clin Pharmacol Ther 1991; 5 (1): 487-97
25. De Boer AG, Breimer DD. The blood-brain barrier: implications for drug delivery to the brain. J R Coll Physicians Lond 1994; 28 (6): 502-6
26. Bradbury MWB. The blood-brain barrier. Exp Physiol 1993; 78: 453-72
27. Reese TS, Karnovsky MJ. Fine structural localisation of a blood-brain barrier to exogenous peroxidase. J Cell Biol 1967; 34: 207-17
28. Bonati M, Kanto J, Tognoni G. Clinical pharmacokinetics of cerebrospinal fluid. Clin Pharmacokinet 1982; 7: 312-35
29. Brodie B, Kurtz H, Schanker L. The importance of dissociation constant and lipid solubility in influencing the passage of drugs into the cerebrospinal fluid. J Pharmacol Exp Ther 1960; 130: 20-5
30. Crone C. The permeability of brain capillaries to non-electrolytes. Acta Physiol Scand 1965; 64: 407-17
31. Van Bree JBM, DeBoer AG, Danhof M, et al. Characterisation of an 'in vitro' blood brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs. J Pharmacol Exp Ther 1988; 247 (3): 1233-9
32. Joo F, Klatzo I. Role of cerebral endothelium in brain oedema. Neurol Res 1989; 11: 67-75
33. Bullock R, Fujisawa H. The role of glutamate antagonists for the treatment of CNS injury. J Neurotrauma 1992; 9 Suppl. 2: 443-61
34. Benzel EC, Gross CD, Hadden TA, et al. The apnea test for determination of brain death. J Neurosurg 1989; 71: 191-4
35. Berger AJ, Mitchell RA, Severingham JW. Regulation of respiration: part I. N Engl J Med 1977; 297 (2): 92-7
36. Berger AJ, Mitchell RA, Severingham JW. Regulation of respiration: part II. N Engl J Med 1977; 297 (3): 138-43
37. Berger AJ, Mitchell RA, Severingham JW. Regulation of respiration: part III. N Engl J Med 1977; 297 (4): 194-201
38. Nunn JF. Control of breathing. Nunn's applied respiratory physiology. 4th ed. London: Butterworth, 1993: 90-116
39. Cohn MA. Hypnotics and the control of breathing: a review. Br J Clin Pharm 1983; 16 Suppl.: 245-50
40. Olson KR, Pentel PR, Kelley MT. Physical assessment and differential diagnosis of the poisoned patient. Med Toxicol 1987; 2: 52-81
41. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurological disorders. N Engl J Med 1994; 330(9): 613-20
42. Mandema JW, Danhof M. Electroencephalogram effect measures and relationship between pharmacokinetics and pharmacodynamics of centrally acting drugs. Clin Pharmacokinet 1992; 23(3): 191-215
43. Powner DJ. Drug associated isoelectric EEGs: a hazard in brain-death certification. JAMA 1976; 236: 1123
44. Setzer N. Brain death: physiologic definitions. Crit Care Clin 1985; 1 (2): 375-96
45. Taylor MJ, Houston BD, Lowry NJ. Recovery of auditory brain-stem responses after a severe hypoxic ischaemic insult. N Engl J Med 1983; 309: 1169-70
46. Levine SR, Brust JCM, Furtell N, et al. Cerebrovascular complications of the use of the 'crack' form of alkaloidal cocaine. N Engl J Med 1990; 3 23: 699-704
47. Bucthal F, Svensmark O, Schiller PJ. Clinical and electroencephalographic correlation with serum levels of diphenylhydantoin. Arch Neurol 1960; 2: 624-30
48. Lund L. Anticonvulsant effect of diphenylhydantoin relative to plasma levels. Arch Neurol 1974; 31 (5): 289-94
49. Ingelfinger JA, Isakson G, Shine D, et al. Reliability of the toxic-screen in overdose. Clin Pharmacol Ther 1981; 29 (5) 570-95
50. Spiechler VR, O'Donnell CM, Gokhale DV. Confirmation and certainty in toxicology screening. Clin Chem 1988; 34 (8) 1535-9
51. ® (pancuronium bromide) during artificial ventilation. Clin Neurol Neurosurg 1985; 87 (1): 17-22
52. Belaesky M, Kalwans HI. Prolonged neuromuscular blockade with pancuronium bromide in a young healthy woman. Anaesthesiology 1971; 40 (3): 295-6
53. Segredo V, Caldwell JE, Marthay MA, et al. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992; 327: 524-8
54. Tyson RN. Simulation of cerebral death by succinylcholine sensitivity. Arch Neurol 1974; 30: 409-11
55. Shapiro HM. Barbiturates in brain ischaemia. Br J Anaesth 1985; 57: 82-95
56. Scatton B, Carter C, Benavides J, et al. N-Methyl-D-Aspartate receptor antagonists: a novel therapeutic perspective for the treatment of ischaemic brain injury. Cerebrovasc Dis 1991; 1: 121-35
57. Fitzpatrick AJ, Crawford M, Allan RM, et al. Aconite poisoning managed with a ventricular assist device. Anaesth Intensive Care 1994; 22: 714-7